Time to event analyses did not demonstrate statistically significant associations for parasomnia, disturbed sleep, restless legs syndrome, or narcolepsy/cataplexy
In controlled in-vitro and analytical systems, LC526 (Lipo C 526) supports study of mitochondrial long-chain fatty acid transport via the L-Carnitine/CPT shuttle, NAD/NADH ratio dynamics through included NADH, hepatic lipotropic signaling via the MIC complex (Methionine, Inositol, Choline), and one-carbon methylation biology through Methionine and Vitamin B12 cofactors
These symptoms are usually dose-related and often improve with slower dose increases, smaller meals, hydration, and avoiding overeating
They are mentioned for comparison purposes only